Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Baxter International (NY: BAX )

34.01 +0.40 (+1.19%)
Official Closing Price Updated: 7:00 PM EDT, Jul 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,687,584
Open 33.79
Bid (Size) 33.45 (10)
Ask (Size) 34.35 (3)
Prev. Close 33.61
Today's Range 33.38 - 34.11
52wk Range 31.01 - 50.21
Shares Outstanding 499,910,255
Dividend Yield 3.41%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Bargain Bin Stocks with Millionaire-Maker Potential
Three bargain stocks with substantial upside from potential price-to-earnings multiple reratings and accretive buybacks. 
Via InvestorPlace
Carlyle Eyes $4B Acquisition Of Baxter's Kidney-Care Unit Vantive: Report
Carlyle is negotiating to acquire Baxter International's kidney-care spinoff, Vantive, in a $4 billion deal, including debt. The deal reflects a significant move in private-equity dealmaking and... 
Via Benzinga

Performance

YTD
-12.46%
-12.46%
1 Month
+3.41%
+3.41%
3 Month
-20.59%
-20.59%
6 Month
-16.36%
-16.36%
1 Year
-25.50%
-25.50%

More News

Read More
“Cash Flow Is The Name Of The Game” Stock Market
Via Talk Markets
Topics Economy
Exposures Interest Rates
Assessing Baxter Intl: Insights From 4 Financial Analysts
Via Benzinga
How Is The Market Feeling About Baxter Intl?
Via Benzinga
Baxter to Present at Goldman Sachs 45th Annual Global Healthcare Conference
From Baxter International Inc.
Via Business Wire
Unveiling 5 Analyst Insights On Baxter Intl
Via Benzinga
(BAX) - Analyzing Baxter Intl's Short Interest
Via Benzinga
A Glimpse Into The Expert Outlook On Baxter Intl Through 4 Analysts
Via Benzinga
7 Deeply Undervalued Stocks to Buy Now or Regret Later
Via InvestorPlace
New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
From Baxter International Inc.
Via Business Wire
3 Dividend Growth Stocks For Long-Term Returns
Via Talk Markets
Baxter to Present at Jefferies 2024 Global Healthcare Conference
From Baxter International Inc.
Via Business Wire
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
Via Benzinga
Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers
Via Benzinga
Baxter Announces Mission and Logo for Proposed Kidney Care Company Vantive
From Baxter International Inc.
Via Business Wire
Baxter Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication
From Baxter International Inc.
Via Business Wire
Baxter to Present at Bank of America 2024 Health Care Conference
From Baxter International Inc.
Via Business Wire
Baxter Declares Quarterly Dividend
From Baxter International Inc.
Via Business Wire
Why Is Nuvo Group (NUVO) Stock Up 200% Today?
Via InvestorPlace
The Big Split: 3 Stock Spinoffs Are Coming. Should You Buy?
Via InvestorPlace
Why Is Medical Device Maker Baxter Stock Trading Lower On Thursday?
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
BAX Stock Earnings: Baxter Intl Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Baxter Reports First-Quarter 2024 Results
From Baxter International Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.